Eli Lilly delays its clinical trials during Coronavirus pandemic Medical Dialogues Bureau25 March 2020 9:30 AM GMTIndianapolis: Eli Lilly and Company has provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company wi...
Eli Lilly Completes Acquisition of Dermira Medical Dialogues Bureau22 Feb 2020 4:15 AM GMT INDIANAPOLIS : Eli Lilly and Company has announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition exp...
Eli Lilly to provide Migraine drug Reyvow Farhat Nasim4 Feb 2020 3:30 AM GMTNew Delhi: Eli Lilly and Company announced recently that REYVOW (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment o...
Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA Farhat Nasim3 Feb 2020 9:33 AM GMTThe CHMP opinion is now referred for final action to the European Commission, which grants approval in the European Union. Lilly plans to market the me...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 4:30 AM GMTBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest biddin...
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO Medical Dialogues Bureau17 Jan 2020 7:15 AM GMTSan Francisco: Eli Lilly and Co aim to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in...
